Glycogen synthase kinase 3 beta: can it be a target for oral cancer
<p>Abstract</p> <p>Despite progress in treatment approaches for oral cancer, there has been only modest improvement in patient outcomes in the past three decades. The frequent treatment failure is due to the failure to control tumor recurrence and metastasis. These failures suggest...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/144 |